Skip to content
10-Q

Quarterly Report

QLY BIOTECH GROUP CORP.

0001477932-23-002473

← back to feed
Filed
Apr 13, 2023 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Apr 13, 2023 3.9M sh
Operating Cash Flow Q2 2023 · Feb 28, 2023 −$15.94K
Operating Cash Flow Q2 2023 · Feb 28, 2022 −$6.64K
Stockholders Equity Q2 2023 · Feb 28, 2023 −$19.67K
Stockholders Equity Q2 2023 · Nov 30, 2022 −$8.05K
Stockholders Equity Q2 2023 · Aug 31, 2022 $0
Stockholders Equity restated Q2 2023 · Feb 28, 2022 −$11.93K
Stockholders Equity Q2 2023 · Nov 30, 2021 −$10.18K
Stockholders Equity Q2 2023 · Aug 31, 2021 −$5.96K
Current Liabilities Q2 2023 · Feb 28, 2023 $19.67K
Current Liabilities Q2 2023 · Aug 31, 2022 $0
Total Liabilities Q2 2023 · Feb 28, 2023 $19.67K
Total Liabilities Q2 2023 · Aug 31, 2022 $0
Total Assets Q2 2023 · Feb 28, 2023 $0
Total Assets Q2 2023 · Aug 31, 2022 $0
Sga Expense Q2 2023 · Feb 28, 2023 $11.62K
Sga Expense Q2 2023 · Feb 28, 2023 $20.79K
Sga Expense Q2 2023 · Feb 28, 2022 $1.76K
Sga Expense Q2 2023 · Feb 28, 2022 $5.97K
Net Income Q2 2023 · Feb 28, 2023 −$11.62K
Net Income Q2 2023 · Feb 28, 2023 −$20.79K
Net Income Q2 2023 · Nov 30, 2022 −$9.17K
Net Income Q2 2023 · Feb 28, 2022 −$1.76K
Net Income Q2 2023 · Feb 28, 2022 −$5.97K
Net Income Q2 2023 · Nov 30, 2021 −$4.21K
Gross Profit Q2 2023 · Feb 28, 2023 $0
Gross Profit Q2 2023 · Feb 28, 2023 $0
Gross Profit Q2 2023 · Feb 28, 2022 $0
Gross Profit Q2 2023 · Feb 28, 2022 $0
Cost Of Revenue Q2 2023 · Feb 28, 2023 $0
Cost Of Revenue Q2 2023 · Feb 28, 2023 $0
Cost Of Revenue Q2 2023 · Feb 28, 2022 $0
Cost Of Revenue Q2 2023 · Feb 28, 2022 $0
Revenue Q2 2023 · Feb 28, 2023 $0
Revenue Q2 2023 · Feb 28, 2023 $0
Revenue Q2 2023 · Feb 28, 2022 $0
Revenue Q2 2023 · Feb 28, 2022 $0